On April 26, 2013, the U.S. Food and Drug Administration (FDA) issued a safety alert regarding the anti-seizure medication Potiga (ezogabine). Potiga is used to treat partial-onset seizures in adults with epilepsy. Epilepsy is a brain disorder that causes recurring seizures. Approximately 60,000people in Connecticut have epilepsy. One out of every ten people will experience a seizure at some point in their lives. [...]

Recent Comments